Serum calciprotein particle‐to‐phosphate ratio as a predictor of cardiovascular events in incident hemodialysis patients
Therapeutic Apheresis and Dialysis · 2025
DOI: 10.1111/1744-9987.14203 ↗Kurz gefasst
Fachartikel in der Zeitschrift Therapeutic Apheresis and Dialysis, 2025. Verfasst von Tomoki Akiyama und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan. Hauptthemen laut MEDLINE: Renal Dialysis, Phosphates, Cardiovascular Diseases, Vascular Calcification. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 30 Literaturangaben. Gefördert von: Japan Society for the Promotion of Science (JSPS) KAKENHI, Japan Society for the Promotion of Science.
Abstract (Originalsprache)
Introduction
Recent studies have identified increased blood calciprotein particle (CPP) levels as risk factors for vascular calcification and cardiovascular events in patients undergoing maintenance hemodialysis. Although positively correlated with serum phosphate levels, serum CPP levels vary considerably among patients with similar serum phosphate levels. We investigated the capacity of the ratio of serum CPP levels to serum phosphate levels (CPP/Pi ratio) to predict cardiovascular events in incident hemodialysis patients compared to the serum calcification propensity test (T 50 ). Methods and Results The association between the CPP/Pi ratio and major adverse cardiac and cerebrovascular events (MACCE) was investigated in 174 incident hemodialysis patients. Multivariate analysis revealed that the CPP/Pi ratio was independently associated with MACCE [hazard ratio 1.60, 95% confidence interval (1.15–2.23), p = 0.006] but serum T 50 levels were not.
Conclusions
The CPP/Pi ratio is a useful, novel biomarker for predicting the risk of cardiovascular events in patients undergoing incident hemodialysis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Nephrology, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan.
- Division of Anti-aging Medicine, Center for Molecular Medicine, Jichi Medical University, Shimotsuke, Japan.
- Department of Nephrology, Mito Saiseikai General Hospital, Mito, Japan.
- Department of Renal and Dialysis Medicine, Tsukuba Central Hospital, Ushiku, Japan.
- Central Jin Clinic, Ryugasaki, Japan.
- Department of Nephrology, Tokyo Medical University Ibaraki Medical Center, Ami, Japan.
ORCID-Profile: Tomoki Akiyama
Förderung
- Japan Society for the Promotion of Science (JSPS) KAKENHI
- Japan Society for the Promotion of Science
Zitieren
APA
Akiyama, T., Iwazu, Y., Usui, J., Ebihara, I., Ishizu, T., Kobayashi, M., Maeda, Y., Kobayashi, H., Yamagata, K., Kuro-O, M., & Study Group of the Ibaraki Dialysis Initiation Cohort Study (2025). Serum calciprotein particle‐to‐phosphate ratio as a predictor of cardiovascular events in incident hemodialysis patients. Therapeutic Apheresis and Dialysis. https://doi.org/10.1111/1744-9987.14203
Vancouver
Akiyama T, Iwazu Y, Usui J, Ebihara I, Ishizu T, Kobayashi M, et al. Serum calciprotein particle‐to‐phosphate ratio as a predictor of cardiovascular events in incident hemodialysis patients. Therapeutic Apheresis and Dialysis. 2025. doi:10.1111/1744-9987.14203
BibTeX
@article{Akiyama2025,
author = {Akiyama, Tomoki and Iwazu, Yoshitaka and Usui, Joichi and Ebihara, Itaru and Ishizu, Takashi and Kobayashi, Masaki and Maeda, Yoshitaka and Kobayashi, Hiroaki and Yamagata, Kunihiro and Kuro-O, Makoto and Study Group of the Ibaraki Dialysis Initiation Cohort Study, Study Group of the Ibaraki Dialysis Initiation Cohort Study},
title = {Serum calciprotein particle‐to‐phosphate ratio as a predictor of cardiovascular events in incident hemodialysis patients},
journal = {Therapeutic Apheresis and Dialysis},
year = {2025},
doi = {10.1111/1744-9987.14203}
}
EUVIMED